CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma.
Zheng H, Jiang WH, Tian T, Tan HS, Chen Y, Qiao GL, Han J, Huang SY, Yang Y, Li S, Wang ZG, Gao R, Ren H, Xing H, Ni JS, Wang LH, Ma LJ, Zhou WP.
Zheng H, et al.
Oncotarget. 2017 Mar 21;8(12):18872-18884. doi: 10.18632/oncotarget.14770.
Oncotarget. 2017.
PMID: 28122351
Free PMC article.